Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B Patients (PAS)

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2016 by Foundation for Liver Research
Sponsor:
Collaborator:
Hoffmann-La Roche
Information provided by (Responsible Party):
Foundation for Liver Research
ClinicalTrials.gov Identifier:
NCT01373684
First received: June 14, 2011
Last updated: August 9, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2018
  Estimated Primary Completion Date: June 2018 (Final data collection date for primary outcome measure)